nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—CYP2D6—breast cancer	0.221	1	CbGaD
Niacin—SLC16A1—Methotrexate—breast cancer	0.058	0.458	CbGbCtD
Niacin—CYP2D6—Idarubicin—breast cancer	0.0284	0.224	CbGbCtD
Niacin—CYP2D6—Vinorelbine—breast cancer	0.0139	0.11	CbGbCtD
Niacin—CYP2D6—Tamoxifen—breast cancer	0.0125	0.0989	CbGbCtD
Niacin—CYP2D6—Vinblastine—breast cancer	0.00855	0.0675	CbGbCtD
Niacin—NNMT—mammary gland—breast cancer	0.00584	0.0531	CbGeAlD
Niacin—HCAR2—skin of body—breast cancer	0.0055	0.05	CbGeAlD
Niacin—HCAR3—endocrine gland—breast cancer	0.00548	0.0499	CbGeAlD
Niacin—CYP2D6—Doxorubicin—breast cancer	0.00525	0.0415	CbGbCtD
Niacin—QPRT—female reproductive system—breast cancer	0.00512	0.0466	CbGeAlD
Niacin—NNMT—nipple—breast cancer	0.00483	0.0439	CbGeAlD
Niacin—HCAR2—adipose tissue—breast cancer	0.00467	0.0425	CbGeAlD
Niacin—QPRT—endocrine gland—breast cancer	0.00434	0.0394	CbGeAlD
Niacin—HCAR2—endocrine gland—breast cancer	0.00363	0.0331	CbGeAlD
Niacin—SLC16A3—Azacitidine—Gemcitabine—breast cancer	0.00326	1	CbGdCrCtD
Niacin—NNMT—endometrium—breast cancer	0.00291	0.0265	CbGeAlD
Niacin—NNMT—uterus—breast cancer	0.00269	0.0244	CbGeAlD
Niacin—NNMT—pituitary gland—breast cancer	0.00264	0.024	CbGeAlD
Niacin—NNMT—adipose tissue—breast cancer	0.00263	0.0239	CbGeAlD
Niacin—HCAR2—lymph node—breast cancer	0.00251	0.0229	CbGeAlD
Niacin—NNMT—female reproductive system—breast cancer	0.00241	0.022	CbGeAlD
Niacin—NNMT—adrenal gland—breast cancer	0.00236	0.0214	CbGeAlD
Niacin—NNMT—bone marrow—breast cancer	0.00228	0.0207	CbGeAlD
Niacin—SLC16A3—epithelium—breast cancer	0.00222	0.0202	CbGeAlD
Niacin—NNMT—female gonad—breast cancer	0.0022	0.02	CbGeAlD
Niacin—SLCO2B1—mammary gland—breast cancer	0.00208	0.019	CbGeAlD
Niacin—NNMT—endocrine gland—breast cancer	0.00204	0.0186	CbGeAlD
Niacin—SLC16A3—endometrium—breast cancer	0.00199	0.0181	CbGeAlD
Niacin—SLC16A3—uterus—breast cancer	0.00183	0.0167	CbGeAlD
Niacin—SLC16A3—pituitary gland—breast cancer	0.0018	0.0164	CbGeAlD
Niacin—SLC16A3—adipose tissue—breast cancer	0.00179	0.0163	CbGeAlD
Niacin—SLC16A3—female reproductive system—breast cancer	0.00165	0.015	CbGeAlD
Niacin—SLC16A3—adrenal gland—breast cancer	0.00161	0.0146	CbGeAlD
Niacin—SLC16A3—bone marrow—breast cancer	0.00156	0.0142	CbGeAlD
Niacin—SLC16A3—female gonad—breast cancer	0.0015	0.0137	CbGeAlD
Niacin—NNMT—lymph node—breast cancer	0.00141	0.0129	CbGeAlD
Niacin—SLC16A3—endocrine gland—breast cancer	0.0014	0.0127	CbGeAlD
Niacin—SLC22A5—mammary gland—breast cancer	0.00138	0.0126	CbGeAlD
Niacin—SLC16A1—epithelium—breast cancer	0.00135	0.0123	CbGeAlD
Niacin—SLC16A1—endometrium—breast cancer	0.00121	0.011	CbGeAlD
Niacin—SLC22A5—nipple—breast cancer	0.00114	0.0104	CbGeAlD
Niacin—SLC16A1—uterus—breast cancer	0.00111	0.0101	CbGeAlD
Niacin—SLC16A1—pituitary gland—breast cancer	0.00109	0.00996	CbGeAlD
Niacin—SLC16A1—adipose tissue—breast cancer	0.00109	0.00992	CbGeAlD
Niacin—SLC16A1—female reproductive system—breast cancer	0.001	0.00912	CbGeAlD
Niacin—Metyrapone—CYP3A4—breast cancer	0.000994	0.403	CrCbGaD
Niacin—SLC16A1—adrenal gland—breast cancer	0.000978	0.0089	CbGeAlD
Niacin—SLC16A3—lymph node—breast cancer	0.000965	0.00878	CbGeAlD
Niacin—SLCO2B1—uterus—breast cancer	0.000959	0.00872	CbGeAlD
Niacin—SLCO2B1—adipose tissue—breast cancer	0.000938	0.00853	CbGeAlD
Niacin—SLC16A1—female gonad—breast cancer	0.000912	0.0083	CbGeAlD
Niacin—SLCO2B1—female reproductive system—breast cancer	0.000862	0.00784	CbGeAlD
Niacin—SLC16A1—endocrine gland—breast cancer	0.000848	0.00772	CbGeAlD
Niacin—SLCO2B1—adrenal gland—breast cancer	0.000841	0.00765	CbGeAlD
Niacin—SLCO2B1—female gonad—breast cancer	0.000784	0.00714	CbGeAlD
Niacin—SLC22A5—skin of body—breast cancer	0.000733	0.00667	CbGeAlD
Niacin—SLCO2B1—endocrine gland—breast cancer	0.000729	0.00664	CbGeAlD
Niacin—SLC22A5—endometrium—breast cancer	0.000691	0.00629	CbGeAlD
Niacin—SLC22A5—pituitary gland—breast cancer	0.000625	0.00569	CbGeAlD
Niacin—SLC22A5—adipose tissue—breast cancer	0.000623	0.00567	CbGeAlD
Niacin—SLC16A1—lymph node—breast cancer	0.000586	0.00533	CbGeAlD
Niacin—Salicylic acid—PTGS1—breast cancer	0.000574	0.233	CrCbGaD
Niacin—SLC22A5—female reproductive system—breast cancer	0.000572	0.00521	CbGeAlD
Niacin—SLC22A5—adrenal gland—breast cancer	0.000559	0.00508	CbGeAlD
Niacin—SLC22A5—female gonad—breast cancer	0.000521	0.00474	CbGeAlD
Niacin—SLCO2B1—lymph node—breast cancer	0.000504	0.00459	CbGeAlD
Niacin—CYP2D6—female reproductive system—breast cancer	0.000369	0.00336	CbGeAlD
Niacin—CYP2D6—female gonad—breast cancer	0.000336	0.00306	CbGeAlD
Niacin—SLC22A5—lymph node—breast cancer	0.000335	0.00305	CbGeAlD
Niacin—Salicylic acid—PTGS2—breast cancer	0.000328	0.133	CrCbGaD
Niacin—CYP2D6—endocrine gland—breast cancer	0.000313	0.00284	CbGeAlD
Niacin—Salicylic acid—ALB—breast cancer	0.000292	0.118	CrCbGaD
Niacin—Salicylic acid—ABCB1—breast cancer	0.000279	0.113	CrCbGaD
Niacin—Haemorrhage—Epirubicin—breast cancer	6.61e-05	0.000214	CcSEcCtD
Niacin—Hepatitis—Epirubicin—breast cancer	6.61e-05	0.000214	CcSEcCtD
Niacin—Eye disorder—Methotrexate—breast cancer	6.61e-05	0.000214	CcSEcCtD
Niacin—Diarrhoea—Fluorouracil—breast cancer	6.6e-05	0.000213	CcSEcCtD
Niacin—Tinnitus—Methotrexate—breast cancer	6.59e-05	0.000213	CcSEcCtD
Niacin—Tachycardia—Capecitabine—breast cancer	6.58e-05	0.000213	CcSEcCtD
Niacin—Hypoaesthesia—Epirubicin—breast cancer	6.58e-05	0.000213	CcSEcCtD
Niacin—Skin disorder—Capecitabine—breast cancer	6.55e-05	0.000212	CcSEcCtD
Niacin—Sweating—Doxorubicin—breast cancer	6.54e-05	0.000211	CcSEcCtD
Niacin—Urticaria—Paclitaxel—breast cancer	6.53e-05	0.000211	CcSEcCtD
Niacin—Hyperhidrosis—Capecitabine—breast cancer	6.52e-05	0.000211	CcSEcCtD
Niacin—Oedema peripheral—Epirubicin—breast cancer	6.52e-05	0.000211	CcSEcCtD
Niacin—Hypotension—Docetaxel—breast cancer	6.51e-05	0.00021	CcSEcCtD
Niacin—Abdominal pain—Paclitaxel—breast cancer	6.5e-05	0.00021	CcSEcCtD
Niacin—Body temperature increased—Paclitaxel—breast cancer	6.5e-05	0.00021	CcSEcCtD
Niacin—Anorexia—Capecitabine—breast cancer	6.43e-05	0.000208	CcSEcCtD
Niacin—Angiopathy—Methotrexate—breast cancer	6.41e-05	0.000207	CcSEcCtD
Niacin—Vomiting—Mitoxantrone—breast cancer	6.41e-05	0.000207	CcSEcCtD
Niacin—Vomiting—Irinotecan—breast cancer	6.41e-05	0.000207	CcSEcCtD
Niacin—Dizziness—Fluorouracil—breast cancer	6.38e-05	0.000206	CcSEcCtD
Niacin—Visual impairment—Epirubicin—breast cancer	6.37e-05	0.000206	CcSEcCtD
Niacin—Rash—Mitoxantrone—breast cancer	6.35e-05	0.000205	CcSEcCtD
Niacin—Rash—Irinotecan—breast cancer	6.35e-05	0.000205	CcSEcCtD
Niacin—Dermatitis—Irinotecan—breast cancer	6.35e-05	0.000205	CcSEcCtD
Niacin—Dermatitis—Mitoxantrone—breast cancer	6.35e-05	0.000205	CcSEcCtD
Niacin—Musculoskeletal discomfort—Docetaxel—breast cancer	6.35e-05	0.000205	CcSEcCtD
Niacin—Chills—Methotrexate—breast cancer	6.34e-05	0.000205	CcSEcCtD
Niacin—Headache—Irinotecan—breast cancer	6.31e-05	0.000204	CcSEcCtD
Niacin—Headache—Mitoxantrone—breast cancer	6.31e-05	0.000204	CcSEcCtD
Niacin—Hypotension—Capecitabine—breast cancer	6.3e-05	0.000204	CcSEcCtD
Niacin—Insomnia—Docetaxel—breast cancer	6.3e-05	0.000204	CcSEcCtD
Niacin—Paraesthesia—Docetaxel—breast cancer	6.26e-05	0.000202	CcSEcCtD
Niacin—Alopecia—Methotrexate—breast cancer	6.25e-05	0.000202	CcSEcCtD
Niacin—Vomiting—Gemcitabine—breast cancer	6.24e-05	0.000202	CcSEcCtD
Niacin—Dyspnoea—Docetaxel—breast cancer	6.21e-05	0.000201	CcSEcCtD
Niacin—Somnolence—Docetaxel—breast cancer	6.19e-05	0.0002	CcSEcCtD
Niacin—Rash—Gemcitabine—breast cancer	6.19e-05	0.0002	CcSEcCtD
Niacin—Dermatitis—Gemcitabine—breast cancer	6.18e-05	0.0002	CcSEcCtD
Niacin—Eye disorder—Epirubicin—breast cancer	6.18e-05	0.0002	CcSEcCtD
Niacin—Tinnitus—Epirubicin—breast cancer	6.17e-05	0.000199	CcSEcCtD
Niacin—Malnutrition—Methotrexate—breast cancer	6.15e-05	0.000199	CcSEcCtD
Niacin—Erythema—Methotrexate—breast cancer	6.15e-05	0.000199	CcSEcCtD
Niacin—Haemoglobin—Doxorubicin—breast cancer	6.15e-05	0.000199	CcSEcCtD
Niacin—Headache—Gemcitabine—breast cancer	6.15e-05	0.000199	CcSEcCtD
Niacin—Musculoskeletal discomfort—Capecitabine—breast cancer	6.15e-05	0.000199	CcSEcCtD
Niacin—Flushing—Epirubicin—breast cancer	6.14e-05	0.000198	CcSEcCtD
Niacin—Vomiting—Fluorouracil—breast cancer	6.14e-05	0.000198	CcSEcCtD
Niacin—Rhinitis—Doxorubicin—breast cancer	6.14e-05	0.000198	CcSEcCtD
Niacin—Dyspepsia—Docetaxel—breast cancer	6.13e-05	0.000198	CcSEcCtD
Niacin—Haemorrhage—Doxorubicin—breast cancer	6.12e-05	0.000198	CcSEcCtD
Niacin—Hepatitis—Doxorubicin—breast cancer	6.12e-05	0.000198	CcSEcCtD
Niacin—Insomnia—Capecitabine—breast cancer	6.1e-05	0.000197	CcSEcCtD
Niacin—Hypoaesthesia—Doxorubicin—breast cancer	6.09e-05	0.000197	CcSEcCtD
Niacin—Rash—Fluorouracil—breast cancer	6.09e-05	0.000197	CcSEcCtD
Niacin—Dermatitis—Fluorouracil—breast cancer	6.08e-05	0.000197	CcSEcCtD
Niacin—Paraesthesia—Capecitabine—breast cancer	6.06e-05	0.000196	CcSEcCtD
Niacin—Decreased appetite—Docetaxel—breast cancer	6.06e-05	0.000196	CcSEcCtD
Niacin—Hypersensitivity—Paclitaxel—breast cancer	6.06e-05	0.000196	CcSEcCtD
Niacin—Headache—Fluorouracil—breast cancer	6.05e-05	0.000195	CcSEcCtD
Niacin—Oedema peripheral—Doxorubicin—breast cancer	6.03e-05	0.000195	CcSEcCtD
Niacin—Gastrointestinal disorder—Docetaxel—breast cancer	6.01e-05	0.000194	CcSEcCtD
Niacin—Dyspnoea—Capecitabine—breast cancer	6.01e-05	0.000194	CcSEcCtD
Niacin—Angiopathy—Epirubicin—breast cancer	6e-05	0.000194	CcSEcCtD
Niacin—Nausea—Mitoxantrone—breast cancer	5.99e-05	0.000194	CcSEcCtD
Niacin—Nausea—Irinotecan—breast cancer	5.99e-05	0.000194	CcSEcCtD
Niacin—Pain—Docetaxel—breast cancer	5.96e-05	0.000193	CcSEcCtD
Niacin—Dyspepsia—Capecitabine—breast cancer	5.94e-05	0.000192	CcSEcCtD
Niacin—Chills—Epirubicin—breast cancer	5.93e-05	0.000192	CcSEcCtD
Niacin—Arrhythmia—Epirubicin—breast cancer	5.91e-05	0.000191	CcSEcCtD
Niacin—Visual impairment—Doxorubicin—breast cancer	5.9e-05	0.000191	CcSEcCtD
Niacin—Asthenia—Paclitaxel—breast cancer	5.9e-05	0.000191	CcSEcCtD
Niacin—Decreased appetite—Capecitabine—breast cancer	5.86e-05	0.00019	CcSEcCtD
Niacin—Alopecia—Epirubicin—breast cancer	5.84e-05	0.000189	CcSEcCtD
Niacin—Nausea—Gemcitabine—breast cancer	5.83e-05	0.000189	CcSEcCtD
Niacin—Gastrointestinal disorder—Capecitabine—breast cancer	5.82e-05	0.000188	CcSEcCtD
Niacin—Pruritus—Paclitaxel—breast cancer	5.82e-05	0.000188	CcSEcCtD
Niacin—Vision blurred—Methotrexate—breast cancer	5.8e-05	0.000187	CcSEcCtD
Niacin—Pain—Capecitabine—breast cancer	5.77e-05	0.000186	CcSEcCtD
Niacin—Malnutrition—Epirubicin—breast cancer	5.76e-05	0.000186	CcSEcCtD
Niacin—Erythema—Epirubicin—breast cancer	5.76e-05	0.000186	CcSEcCtD
Niacin—Nausea—Fluorouracil—breast cancer	5.73e-05	0.000185	CcSEcCtD
Niacin—Eye disorder—Doxorubicin—breast cancer	5.72e-05	0.000185	CcSEcCtD
Niacin—Tinnitus—Doxorubicin—breast cancer	5.71e-05	0.000184	CcSEcCtD
Niacin—Gastrointestinal pain—Docetaxel—breast cancer	5.7e-05	0.000184	CcSEcCtD
Niacin—Flushing—Doxorubicin—breast cancer	5.68e-05	0.000184	CcSEcCtD
Niacin—Flatulence—Epirubicin—breast cancer	5.67e-05	0.000183	CcSEcCtD
Niacin—Tension—Epirubicin—breast cancer	5.65e-05	0.000183	CcSEcCtD
Niacin—Diarrhoea—Paclitaxel—breast cancer	5.62e-05	0.000182	CcSEcCtD
Niacin—Nervousness—Epirubicin—breast cancer	5.59e-05	0.000181	CcSEcCtD
Niacin—Angiopathy—Doxorubicin—breast cancer	5.55e-05	0.000179	CcSEcCtD
Niacin—Muscle spasms—Epirubicin—breast cancer	5.54e-05	0.000179	CcSEcCtD
Niacin—Vertigo—Methotrexate—breast cancer	5.53e-05	0.000179	CcSEcCtD
Niacin—Gastrointestinal pain—Capecitabine—breast cancer	5.52e-05	0.000178	CcSEcCtD
Niacin—Body temperature increased—Docetaxel—breast cancer	5.51e-05	0.000178	CcSEcCtD
Niacin—Abdominal pain—Docetaxel—breast cancer	5.51e-05	0.000178	CcSEcCtD
Niacin—Leukopenia—Methotrexate—breast cancer	5.51e-05	0.000178	CcSEcCtD
Niacin—Chills—Doxorubicin—breast cancer	5.49e-05	0.000178	CcSEcCtD
Niacin—Arrhythmia—Doxorubicin—breast cancer	5.47e-05	0.000177	CcSEcCtD
Niacin—Dizziness—Paclitaxel—breast cancer	5.44e-05	0.000176	CcSEcCtD
Niacin—Vision blurred—Epirubicin—breast cancer	5.43e-05	0.000175	CcSEcCtD
Niacin—Alopecia—Doxorubicin—breast cancer	5.41e-05	0.000175	CcSEcCtD
Niacin—Cough—Methotrexate—breast cancer	5.37e-05	0.000174	CcSEcCtD
Niacin—Urticaria—Capecitabine—breast cancer	5.36e-05	0.000173	CcSEcCtD
Niacin—Abdominal pain—Capecitabine—breast cancer	5.33e-05	0.000172	CcSEcCtD
Niacin—Body temperature increased—Capecitabine—breast cancer	5.33e-05	0.000172	CcSEcCtD
Niacin—Erythema—Doxorubicin—breast cancer	5.33e-05	0.000172	CcSEcCtD
Niacin—Malnutrition—Doxorubicin—breast cancer	5.33e-05	0.000172	CcSEcCtD
Niacin—Flatulence—Doxorubicin—breast cancer	5.25e-05	0.00017	CcSEcCtD
Niacin—Myalgia—Methotrexate—breast cancer	5.24e-05	0.000169	CcSEcCtD
Niacin—Arthralgia—Methotrexate—breast cancer	5.24e-05	0.000169	CcSEcCtD
Niacin—Tension—Doxorubicin—breast cancer	5.23e-05	0.000169	CcSEcCtD
Niacin—Vomiting—Paclitaxel—breast cancer	5.23e-05	0.000169	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	5.2e-05	0.000168	CcSEcCtD
Niacin—Rash—Paclitaxel—breast cancer	5.18e-05	0.000168	CcSEcCtD
Niacin—Dermatitis—Paclitaxel—breast cancer	5.18e-05	0.000167	CcSEcCtD
Niacin—Nervousness—Doxorubicin—breast cancer	5.17e-05	0.000167	CcSEcCtD
Niacin—Vertigo—Epirubicin—breast cancer	5.17e-05	0.000167	CcSEcCtD
Niacin—Syncope—Epirubicin—breast cancer	5.16e-05	0.000167	CcSEcCtD
Niacin—Leukopenia—Epirubicin—breast cancer	5.15e-05	0.000167	CcSEcCtD
Niacin—Headache—Paclitaxel—breast cancer	5.15e-05	0.000166	CcSEcCtD
Niacin—Hypersensitivity—Docetaxel—breast cancer	5.13e-05	0.000166	CcSEcCtD
Niacin—Muscle spasms—Doxorubicin—breast cancer	5.12e-05	0.000166	CcSEcCtD
Niacin—Palpitations—Epirubicin—breast cancer	5.09e-05	0.000164	CcSEcCtD
Niacin—Loss of consciousness—Epirubicin—breast cancer	5.06e-05	0.000164	CcSEcCtD
Niacin—Cough—Epirubicin—breast cancer	5.02e-05	0.000162	CcSEcCtD
Niacin—Anaphylactic shock—Methotrexate—breast cancer	5.02e-05	0.000162	CcSEcCtD
Niacin—Vision blurred—Doxorubicin—breast cancer	5.02e-05	0.000162	CcSEcCtD
Niacin—Asthenia—Docetaxel—breast cancer	5e-05	0.000162	CcSEcCtD
Niacin—Hypersensitivity—Capecitabine—breast cancer	4.97e-05	0.000161	CcSEcCtD
Niacin—Pruritus—Docetaxel—breast cancer	4.93e-05	0.000159	CcSEcCtD
Niacin—Myalgia—Epirubicin—breast cancer	4.9e-05	0.000158	CcSEcCtD
Niacin—Arthralgia—Epirubicin—breast cancer	4.9e-05	0.000158	CcSEcCtD
Niacin—Nausea—Paclitaxel—breast cancer	4.88e-05	0.000158	CcSEcCtD
Niacin—Skin disorder—Methotrexate—breast cancer	4.88e-05	0.000158	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.87e-05	0.000157	CcSEcCtD
Niacin—Hyperhidrosis—Methotrexate—breast cancer	4.85e-05	0.000157	CcSEcCtD
Niacin—Asthenia—Capecitabine—breast cancer	4.84e-05	0.000156	CcSEcCtD
Niacin—Dry mouth—Epirubicin—breast cancer	4.79e-05	0.000155	CcSEcCtD
Niacin—Vertigo—Doxorubicin—breast cancer	4.79e-05	0.000155	CcSEcCtD
Niacin—Anorexia—Methotrexate—breast cancer	4.79e-05	0.000155	CcSEcCtD
Niacin—Syncope—Doxorubicin—breast cancer	4.78e-05	0.000154	CcSEcCtD
Niacin—Pruritus—Capecitabine—breast cancer	4.77e-05	0.000154	CcSEcCtD
Niacin—Leukopenia—Doxorubicin—breast cancer	4.77e-05	0.000154	CcSEcCtD
Niacin—Diarrhoea—Docetaxel—breast cancer	4.77e-05	0.000154	CcSEcCtD
Niacin—Palpitations—Doxorubicin—breast cancer	4.71e-05	0.000152	CcSEcCtD
Niacin—Anaphylactic shock—Epirubicin—breast cancer	4.7e-05	0.000152	CcSEcCtD
Niacin—Oedema—Epirubicin—breast cancer	4.7e-05	0.000152	CcSEcCtD
Niacin—Hypotension—Methotrexate—breast cancer	4.69e-05	0.000152	CcSEcCtD
Niacin—Loss of consciousness—Doxorubicin—breast cancer	4.68e-05	0.000151	CcSEcCtD
Niacin—Cough—Doxorubicin—breast cancer	4.65e-05	0.00015	CcSEcCtD
Niacin—Shock—Epirubicin—breast cancer	4.62e-05	0.000149	CcSEcCtD
Niacin—Diarrhoea—Capecitabine—breast cancer	4.62e-05	0.000149	CcSEcCtD
Niacin—Dizziness—Docetaxel—breast cancer	4.61e-05	0.000149	CcSEcCtD
Niacin—Tachycardia—Epirubicin—breast cancer	4.59e-05	0.000148	CcSEcCtD
Niacin—Musculoskeletal discomfort—Methotrexate—breast cancer	4.57e-05	0.000148	CcSEcCtD
Niacin—Skin disorder—Epirubicin—breast cancer	4.56e-05	0.000148	CcSEcCtD
Niacin—Hyperhidrosis—Epirubicin—breast cancer	4.54e-05	0.000147	CcSEcCtD
Niacin—Insomnia—Methotrexate—breast cancer	4.54e-05	0.000147	CcSEcCtD
Niacin—Arthralgia—Doxorubicin—breast cancer	4.54e-05	0.000147	CcSEcCtD
Niacin—Myalgia—Doxorubicin—breast cancer	4.54e-05	0.000147	CcSEcCtD
Niacin—Paraesthesia—Methotrexate—breast cancer	4.51e-05	0.000146	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.5e-05	0.000146	CcSEcCtD
Niacin—Anorexia—Epirubicin—breast cancer	4.48e-05	0.000145	CcSEcCtD
Niacin—Dyspnoea—Methotrexate—breast cancer	4.48e-05	0.000145	CcSEcCtD
Niacin—Somnolence—Methotrexate—breast cancer	4.46e-05	0.000144	CcSEcCtD
Niacin—Dizziness—Capecitabine—breast cancer	4.46e-05	0.000144	CcSEcCtD
Niacin—Dry mouth—Doxorubicin—breast cancer	4.44e-05	0.000143	CcSEcCtD
Niacin—Vomiting—Docetaxel—breast cancer	4.43e-05	0.000143	CcSEcCtD
Niacin—Dyspepsia—Methotrexate—breast cancer	4.42e-05	0.000143	CcSEcCtD
Niacin—Rash—Docetaxel—breast cancer	4.39e-05	0.000142	CcSEcCtD
Niacin—Hypotension—Epirubicin—breast cancer	4.39e-05	0.000142	CcSEcCtD
Niacin—Dermatitis—Docetaxel—breast cancer	4.39e-05	0.000142	CcSEcCtD
Niacin—Decreased appetite—Methotrexate—breast cancer	4.37e-05	0.000141	CcSEcCtD
Niacin—Headache—Docetaxel—breast cancer	4.36e-05	0.000141	CcSEcCtD
Niacin—Oedema—Doxorubicin—breast cancer	4.35e-05	0.000141	CcSEcCtD
Niacin—Anaphylactic shock—Doxorubicin—breast cancer	4.35e-05	0.000141	CcSEcCtD
Niacin—Gastrointestinal disorder—Methotrexate—breast cancer	4.34e-05	0.00014	CcSEcCtD
Niacin—Pain—Methotrexate—breast cancer	4.29e-05	0.000139	CcSEcCtD
Niacin—Vomiting—Capecitabine—breast cancer	4.29e-05	0.000139	CcSEcCtD
Niacin—Musculoskeletal discomfort—Epirubicin—breast cancer	4.28e-05	0.000138	CcSEcCtD
Niacin—Shock—Doxorubicin—breast cancer	4.28e-05	0.000138	CcSEcCtD
Niacin—Rash—Capecitabine—breast cancer	4.25e-05	0.000137	CcSEcCtD
Niacin—Insomnia—Epirubicin—breast cancer	4.25e-05	0.000137	CcSEcCtD
Niacin—Dermatitis—Capecitabine—breast cancer	4.25e-05	0.000137	CcSEcCtD
Niacin—Tachycardia—Doxorubicin—breast cancer	4.24e-05	0.000137	CcSEcCtD
Niacin—Headache—Capecitabine—breast cancer	4.23e-05	0.000137	CcSEcCtD
Niacin—Skin disorder—Doxorubicin—breast cancer	4.22e-05	0.000137	CcSEcCtD
Niacin—Paraesthesia—Epirubicin—breast cancer	4.22e-05	0.000136	CcSEcCtD
Niacin—Hyperhidrosis—Doxorubicin—breast cancer	4.2e-05	0.000136	CcSEcCtD
Niacin—Dyspnoea—Epirubicin—breast cancer	4.19e-05	0.000135	CcSEcCtD
Niacin—Somnolence—Epirubicin—breast cancer	4.18e-05	0.000135	CcSEcCtD
Niacin—Anorexia—Doxorubicin—breast cancer	4.14e-05	0.000134	CcSEcCtD
Niacin—Nausea—Docetaxel—breast cancer	4.14e-05	0.000134	CcSEcCtD
Niacin—Dyspepsia—Epirubicin—breast cancer	4.14e-05	0.000134	CcSEcCtD
Niacin—Gastrointestinal pain—Methotrexate—breast cancer	4.11e-05	0.000133	CcSEcCtD
Niacin—Decreased appetite—Epirubicin—breast cancer	4.08e-05	0.000132	CcSEcCtD
Niacin—Hypotension—Doxorubicin—breast cancer	4.06e-05	0.000131	CcSEcCtD
Niacin—Gastrointestinal disorder—Epirubicin—breast cancer	4.06e-05	0.000131	CcSEcCtD
Niacin—Pain—Epirubicin—breast cancer	4.02e-05	0.00013	CcSEcCtD
Niacin—Nausea—Capecitabine—breast cancer	4.01e-05	0.00013	CcSEcCtD
Niacin—Urticaria—Methotrexate—breast cancer	3.99e-05	0.000129	CcSEcCtD
Niacin—Body temperature increased—Methotrexate—breast cancer	3.97e-05	0.000128	CcSEcCtD
Niacin—Abdominal pain—Methotrexate—breast cancer	3.97e-05	0.000128	CcSEcCtD
Niacin—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.96e-05	0.000128	CcSEcCtD
Niacin—Insomnia—Doxorubicin—breast cancer	3.93e-05	0.000127	CcSEcCtD
Niacin—Paraesthesia—Doxorubicin—breast cancer	3.9e-05	0.000126	CcSEcCtD
Niacin—Dyspnoea—Doxorubicin—breast cancer	3.88e-05	0.000125	CcSEcCtD
Niacin—Somnolence—Doxorubicin—breast cancer	3.87e-05	0.000125	CcSEcCtD
Niacin—Gastrointestinal pain—Epirubicin—breast cancer	3.84e-05	0.000124	CcSEcCtD
Niacin—Dyspepsia—Doxorubicin—breast cancer	3.83e-05	0.000124	CcSEcCtD
Niacin—Decreased appetite—Doxorubicin—breast cancer	3.78e-05	0.000122	CcSEcCtD
Niacin—Gastrointestinal disorder—Doxorubicin—breast cancer	3.75e-05	0.000121	CcSEcCtD
Niacin—Urticaria—Epirubicin—breast cancer	3.73e-05	0.000121	CcSEcCtD
Niacin—Pain—Doxorubicin—breast cancer	3.72e-05	0.00012	CcSEcCtD
Niacin—Body temperature increased—Epirubicin—breast cancer	3.71e-05	0.00012	CcSEcCtD
Niacin—Abdominal pain—Epirubicin—breast cancer	3.71e-05	0.00012	CcSEcCtD
Niacin—Hypersensitivity—Methotrexate—breast cancer	3.7e-05	0.00012	CcSEcCtD
Niacin—Asthenia—Methotrexate—breast cancer	3.6e-05	0.000116	CcSEcCtD
Niacin—Gastrointestinal pain—Doxorubicin—breast cancer	3.56e-05	0.000115	CcSEcCtD
Niacin—Pruritus—Methotrexate—breast cancer	3.55e-05	0.000115	CcSEcCtD
Niacin—Hypersensitivity—Epirubicin—breast cancer	3.46e-05	0.000112	CcSEcCtD
Niacin—Urticaria—Doxorubicin—breast cancer	3.45e-05	0.000112	CcSEcCtD
Niacin—Body temperature increased—Doxorubicin—breast cancer	3.44e-05	0.000111	CcSEcCtD
Niacin—Abdominal pain—Doxorubicin—breast cancer	3.44e-05	0.000111	CcSEcCtD
Niacin—Diarrhoea—Methotrexate—breast cancer	3.44e-05	0.000111	CcSEcCtD
Niacin—Asthenia—Epirubicin—breast cancer	3.37e-05	0.000109	CcSEcCtD
Niacin—Pruritus—Epirubicin—breast cancer	3.32e-05	0.000107	CcSEcCtD
Niacin—Dizziness—Methotrexate—breast cancer	3.32e-05	0.000107	CcSEcCtD
Niacin—Diarrhoea—Epirubicin—breast cancer	3.22e-05	0.000104	CcSEcCtD
Niacin—Hypersensitivity—Doxorubicin—breast cancer	3.2e-05	0.000104	CcSEcCtD
Niacin—Vomiting—Methotrexate—breast cancer	3.19e-05	0.000103	CcSEcCtD
Niacin—Rash—Methotrexate—breast cancer	3.17e-05	0.000102	CcSEcCtD
Niacin—Dermatitis—Methotrexate—breast cancer	3.16e-05	0.000102	CcSEcCtD
Niacin—Headache—Methotrexate—breast cancer	3.15e-05	0.000102	CcSEcCtD
Niacin—Asthenia—Doxorubicin—breast cancer	3.12e-05	0.000101	CcSEcCtD
Niacin—Dizziness—Epirubicin—breast cancer	3.11e-05	0.0001	CcSEcCtD
Niacin—Pruritus—Doxorubicin—breast cancer	3.08e-05	9.94e-05	CcSEcCtD
Niacin—Vomiting—Epirubicin—breast cancer	2.99e-05	9.66e-05	CcSEcCtD
Niacin—Nausea—Methotrexate—breast cancer	2.98e-05	9.64e-05	CcSEcCtD
Niacin—Diarrhoea—Doxorubicin—breast cancer	2.97e-05	9.62e-05	CcSEcCtD
Niacin—Rash—Epirubicin—breast cancer	2.96e-05	9.58e-05	CcSEcCtD
Niacin—Dermatitis—Epirubicin—breast cancer	2.96e-05	9.57e-05	CcSEcCtD
Niacin—Headache—Epirubicin—breast cancer	2.94e-05	9.52e-05	CcSEcCtD
Niacin—Dizziness—Doxorubicin—breast cancer	2.88e-05	9.29e-05	CcSEcCtD
Niacin—Nausea—Epirubicin—breast cancer	2.79e-05	9.02e-05	CcSEcCtD
Niacin—Vomiting—Doxorubicin—breast cancer	2.76e-05	8.94e-05	CcSEcCtD
Niacin—Rash—Doxorubicin—breast cancer	2.74e-05	8.86e-05	CcSEcCtD
Niacin—Dermatitis—Doxorubicin—breast cancer	2.74e-05	8.85e-05	CcSEcCtD
Niacin—Headache—Doxorubicin—breast cancer	2.72e-05	8.81e-05	CcSEcCtD
Niacin—Nausea—Doxorubicin—breast cancer	2.58e-05	8.35e-05	CcSEcCtD
Niacin—SLC16A1—Metabolism—NCOA3—breast cancer	2.13e-05	9.37e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CB—breast cancer	2.13e-05	9.37e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MTOR—breast cancer	2.13e-05	9.37e-05	CbGpPWpGaD
Niacin—QPRT—Disease—PIK3CA—breast cancer	2.12e-05	9.33e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A2—breast cancer	2.12e-05	9.3e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IGF1—breast cancer	2.11e-05	9.26e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT2—breast cancer	2.11e-05	9.25e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CA—breast cancer	2.08e-05	9.16e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MDM2—breast cancer	2.08e-05	9.13e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCG2—breast cancer	2.07e-05	9.11e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CPT1A—breast cancer	2.07e-05	9.11e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTR—breast cancer	2.07e-05	9.11e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RAF1—breast cancer	2.07e-05	9.09e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RELA—breast cancer	2.06e-05	9.05e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—MTHFR—breast cancer	2.06e-05	9.04e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CXCL8—breast cancer	2.05e-05	9e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—breast cancer	2.05e-05	9e-05	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—GSTM1—breast cancer	2.05e-05	8.99e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—HRAS—breast cancer	2.03e-05	8.94e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HPGDS—breast cancer	2.03e-05	8.94e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CD—breast cancer	2.02e-05	8.89e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HBA1—breast cancer	2.02e-05	8.88e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MTOR—breast cancer	2.02e-05	8.88e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CB—breast cancer	2.02e-05	8.88e-05	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—GSTM1—breast cancer	2.02e-05	8.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SERPINE1—breast cancer	2e-05	8.79e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1B—breast cancer	2e-05	8.79e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—ALB—breast cancer	2e-05	8.78e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CA—breast cancer	1.99e-05	8.75e-05	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—AKT1—breast cancer	1.98e-05	8.69e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ACHE—breast cancer	1.97e-05	8.67e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTT1—breast cancer	1.97e-05	8.67e-05	CbGpPWpGaD
Niacin—QPRT—Disease—HRAS—breast cancer	1.96e-05	8.63e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CASP3—breast cancer	1.96e-05	8.61e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—breast cancer	1.96e-05	8.6e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL6—breast cancer	1.95e-05	8.56e-05	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—ALB—breast cancer	1.95e-05	8.55e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CXCL8—breast cancer	1.94e-05	8.53e-05	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP1A1—breast cancer	1.94e-05	8.53e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—HRAS—breast cancer	1.93e-05	8.48e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—breast cancer	1.93e-05	8.46e-05	CbGpPWpGaD
Niacin—CYP2D6—Metapathway biotransformation—CYP1A1—breast cancer	1.91e-05	8.41e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—NOS3—breast cancer	1.91e-05	8.39e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—breast cancer	1.91e-05	8.38e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—JUN—breast cancer	1.9e-05	8.37e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—CAV1—breast cancer	1.9e-05	8.34e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1B—breast cancer	1.9e-05	8.33e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—breast cancer	1.89e-05	8.3e-05	CbGpPWpGaD
Niacin—QPRT—Disease—IL6—breast cancer	1.88e-05	8.26e-05	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—AKT1—breast cancer	1.88e-05	8.24e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP17A1—breast cancer	1.87e-05	8.21e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CASP3—breast cancer	1.86e-05	8.17e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—breast cancer	1.86e-05	8.15e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MMP9—breast cancer	1.85e-05	8.14e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS1—breast cancer	1.85e-05	8.12e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ENO1—breast cancer	1.85e-05	8.12e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL6—breast cancer	1.85e-05	8.11e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CDKN1A—breast cancer	1.85e-05	8.11e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—HRAS—breast cancer	1.84e-05	8.09e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTEN—breast cancer	1.84e-05	8.09e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2D6—breast cancer	1.81e-05	7.97e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—breast cancer	1.81e-05	7.95e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—RAF1—breast cancer	1.81e-05	7.94e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—JUN—breast cancer	1.8e-05	7.93e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK8—breast cancer	1.8e-05	7.92e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—AKT1—breast cancer	1.8e-05	7.9e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—breast cancer	1.79e-05	7.87e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOA2—breast cancer	1.78e-05	7.82e-05	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CA—breast cancer	1.78e-05	7.81e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CB—breast cancer	1.76e-05	7.75e-05	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—RAF1—breast cancer	1.76e-05	7.73e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MMP9—breast cancer	1.76e-05	7.72e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CDKN1A—breast cancer	1.75e-05	7.69e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTEN—breast cancer	1.75e-05	7.67e-05	CbGpPWpGaD
Niacin—QPRT—Disease—AKT1—breast cancer	1.73e-05	7.62e-05	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—ALB—breast cancer	1.73e-05	7.6e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—breast cancer	1.73e-05	7.59e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—FASN—breast cancer	1.73e-05	7.58e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BCHE—breast cancer	1.72e-05	7.55e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK8—breast cancer	1.71e-05	7.51e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SRC—breast cancer	1.71e-05	7.51e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—AKT1—breast cancer	1.7e-05	7.48e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC5A5—breast cancer	1.7e-05	7.46e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—breast cancer	1.66e-05	7.31e-05	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CA—breast cancer	1.65e-05	7.26e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—breast cancer	1.65e-05	7.24e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NQO1—breast cancer	1.64e-05	7.2e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—SLC2A1—breast cancer	1.64e-05	7.2e-05	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—AKT1—breast cancer	1.63e-05	7.15e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—breast cancer	1.62e-05	7.12e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SRC—breast cancer	1.62e-05	7.11e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP3A4—breast cancer	1.6e-05	7.03e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—breast cancer	1.58e-05	6.93e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MAPK3—breast cancer	1.57e-05	6.91e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1B1—breast cancer	1.57e-05	6.91e-05	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—RAF1—breast cancer	1.56e-05	6.87e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—breast cancer	1.56e-05	6.86e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SYNJ2—breast cancer	1.56e-05	6.86e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HSP90AA1—breast cancer	1.54e-05	6.77e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—breast cancer	1.53e-05	6.73e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TGFB1—breast cancer	1.53e-05	6.71e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CD—breast cancer	1.52e-05	6.67e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOA1—breast cancer	1.5e-05	6.59e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ALB—breast cancer	1.5e-05	6.59e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—breast cancer	1.5e-05	6.58e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MAPK3—breast cancer	1.49e-05	6.56e-05	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—ALB—breast cancer	1.49e-05	6.53e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP19A1—breast cancer	1.48e-05	6.49e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—STK11—breast cancer	1.48e-05	6.49e-05	CbGpPWpGaD
Niacin—QPRT—Metabolism—AKT1—breast cancer	1.45e-05	6.38e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NDUFS3—breast cancer	1.45e-05	6.38e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—breast cancer	1.45e-05	6.38e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TGFB1—breast cancer	1.45e-05	6.36e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—NOS3—breast cancer	1.43e-05	6.3e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—breast cancer	1.42e-05	6.24e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—KRAS—breast cancer	1.41e-05	6.21e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—SRC—breast cancer	1.41e-05	6.21e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—breast cancer	1.38e-05	6.05e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—COMT—breast cancer	1.37e-05	6.04e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTP1—breast cancer	1.37e-05	6.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CHST9—breast cancer	1.36e-05	6e-05	CbGpPWpGaD
Niacin—NNMT—Metabolism—AKT1—breast cancer	1.35e-05	5.93e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—HMOX1—breast cancer	1.35e-05	5.93e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ITPR1—breast cancer	1.35e-05	5.91e-05	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—RAF1—breast cancer	1.34e-05	5.91e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—KRAS—breast cancer	1.34e-05	5.89e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CB—breast cancer	1.32e-05	5.82e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTGS2—breast cancer	1.31e-05	5.76e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—MAPK3—breast cancer	1.3e-05	5.72e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CA—breast cancer	1.3e-05	5.71e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ABCB1—breast cancer	1.29e-05	5.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—COX11—breast cancer	1.29e-05	5.68e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—TYMS—breast cancer	1.27e-05	5.59e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TGFB1—breast cancer	1.26e-05	5.55e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—breast cancer	1.26e-05	5.52e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GSTM1—breast cancer	1.26e-05	5.52e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PLA2G4A—breast cancer	1.26e-05	5.52e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NCOR1—breast cancer	1.26e-05	5.52e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CA—breast cancer	1.23e-05	5.41e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—GPX1—breast cancer	1.2e-05	5.29e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HRAS—breast cancer	1.2e-05	5.28e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—breast cancer	1.19e-05	5.24e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP1A1—breast cancer	1.19e-05	5.23e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SHMT1—breast cancer	1.18e-05	5.2e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CDA—breast cancer	1.18e-05	5.2e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ERCC2—breast cancer	1.18e-05	5.19e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—KRAS—breast cancer	1.17e-05	5.14e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL6—breast cancer	1.15e-05	5.06e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PTEN—breast cancer	1.14e-05	5.03e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HRAS—breast cancer	1.14e-05	5.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLCO1B1—breast cancer	1.14e-05	5e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A5—breast cancer	1.14e-05	5e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—MTHFR—breast cancer	1.11e-05	4.88e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—APRT—breast cancer	1.1e-05	4.83e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL6—breast cancer	1.09e-05	4.79e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CA—breast cancer	1.07e-05	4.72e-05	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—AKT1—breast cancer	1.06e-05	4.66e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—breast cancer	1.04e-05	4.57e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ESRRA—breast cancer	1.03e-05	4.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ANGPTL4—breast cancer	1.03e-05	4.54e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CAV1—breast cancer	1.02e-05	4.5e-05	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—AKT1—breast cancer	1.01e-05	4.42e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—HRAS—breast cancer	9.94e-06	4.37e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HADHB—breast cancer	9.8e-06	4.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPI—breast cancer	9.8e-06	4.31e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDH7A1—breast cancer	9.35e-06	4.11e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDH1A1—breast cancer	9.35e-06	4.11e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—breast cancer	9.33e-06	4.1e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PHGDH—breast cancer	8.96e-06	3.94e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—UMPS—breast cancer	8.96e-06	3.94e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NME1—breast cancer	8.96e-06	3.94e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ADSL—breast cancer	8.96e-06	3.94e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FHL2—breast cancer	8.96e-06	3.94e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BRIP1—breast cancer	8.79e-06	3.86e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—LDHB—breast cancer	8.79e-06	3.86e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPSE—breast cancer	8.79e-06	3.86e-05	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—AKT1—breast cancer	8.78e-06	3.86e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMMR—breast cancer	8.33e-06	3.66e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA3—breast cancer	8.33e-06	3.66e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCC1—breast cancer	8.33e-06	3.66e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CD—breast cancer	8.2e-06	3.6e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ALB—breast cancer	8.1e-06	3.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PPARGC1B—breast cancer	8.07e-06	3.55e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CA—breast cancer	8.07e-06	3.55e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—NOS3—breast cancer	7.74e-06	3.4e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CA9—breast cancer	7.62e-06	3.35e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA4—breast cancer	7.62e-06	3.35e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA2—breast cancer	7.43e-06	3.26e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPX2—breast cancer	7.43e-06	3.26e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPX4—breast cancer	7.34e-06	3.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SULT1A1—breast cancer	7.34e-06	3.22e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—IDH1—breast cancer	7.17e-06	3.15e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTA1—breast cancer	7.17e-06	3.15e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CB—breast cancer	7.15e-06	3.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NAT2—breast cancer	7.09e-06	3.11e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTGS2—breast cancer	7.08e-06	3.11e-05	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—AKT1—breast cancer	6.59e-06	2.9e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—DPYD—breast cancer	6.21e-06	2.73e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MED12—breast cancer	6.21e-06	2.73e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PTEN—breast cancer	6.18e-06	2.71e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALDOA—breast cancer	6.12e-06	2.69e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA3—breast cancer	5.94e-06	2.61e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A2—breast cancer	5.9e-06	2.59e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCG2—breast cancer	5.78e-06	2.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CPT1A—breast cancer	5.78e-06	2.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTR—breast cancer	5.78e-06	2.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HPGDS—breast cancer	5.67e-06	2.49e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HBA1—breast cancer	5.63e-06	2.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTT1—breast cancer	5.49e-06	2.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ACHE—breast cancer	5.49e-06	2.41e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP17A1—breast cancer	5.2e-06	2.29e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS1—breast cancer	5.15e-06	2.26e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENO1—breast cancer	5.15e-06	2.26e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA2—breast cancer	4.96e-06	2.18e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—FASN—breast cancer	4.81e-06	2.11e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BCHE—breast cancer	4.79e-06	2.1e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC5A5—breast cancer	4.73e-06	2.08e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—SLC2A1—breast cancer	4.57e-06	2.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NQO1—breast cancer	4.57e-06	2.01e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP3A4—breast cancer	4.45e-06	1.96e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1B1—breast cancer	4.38e-06	1.92e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CA—breast cancer	4.36e-06	1.92e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HSP90AA1—breast cancer	4.29e-06	1.89e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOA1—breast cancer	4.18e-06	1.84e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—STK11—breast cancer	4.12e-06	1.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP19A1—breast cancer	4.12e-06	1.81e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—COMT—breast cancer	3.83e-06	1.68e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTP1—breast cancer	3.81e-06	1.67e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—HMOX1—breast cancer	3.76e-06	1.65e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ITPR1—breast cancer	3.75e-06	1.65e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ABCB1—breast cancer	3.61e-06	1.58e-05	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—AKT1—breast cancer	3.56e-06	1.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—TYMS—breast cancer	3.54e-06	1.56e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NCOR1—breast cancer	3.5e-06	1.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PLA2G4A—breast cancer	3.5e-06	1.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GSTM1—breast cancer	3.5e-06	1.54e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—GPX1—breast cancer	3.35e-06	1.47e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP1A1—breast cancer	3.32e-06	1.46e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ERCC2—breast cancer	3.29e-06	1.45e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—MTHFR—breast cancer	3.09e-06	1.36e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CAV1—breast cancer	2.85e-06	1.25e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—breast cancer	2.6e-06	1.14e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CD—breast cancer	2.28e-06	1e-05	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ALB—breast cancer	2.26e-06	9.91e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—NOS3—breast cancer	2.16e-06	9.48e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CB—breast cancer	1.99e-06	8.75e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTGS2—breast cancer	1.97e-06	8.67e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PTEN—breast cancer	1.72e-06	7.56e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CA—breast cancer	1.21e-06	5.33e-06	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—AKT1—breast cancer	9.92e-07	4.36e-06	CbGpPWpGaD
